OncoCyte Corporation (OCX) EPS Estimated At $-0.09 as of April, 1 – K Reviewer

OncoCyte Corporation (OCX) EPS Estimated At $-0.09 as of April, 1 K Reviewer

OncoCyte Corporation (NYSEAMERICAN:OCX)’s earnings report is awaited by WallStreet on April, 1, according to Faxor. Analysts have expectation on stock’s …